About Hepatocyte nuclear factor 6
Hepatocyte nuclear factor 6 (ONECUT1) is a protein
from Homo sapiens identified by UniProt accession
Q9UBC0, 465 residues long.
MolForge cross-references it against 0 known binders and
173 disease associations.
Target properties
| Protein name | Hepatocyte nuclear factor 6 |
| UniProt accession | Q9UBC0 |
| Gene | ONECUT1 |
| Organism | Homo sapiens |
| Length | 465 residues |
| Molecular weight | — |
| EC numbers | — |
| Target class | UNCLASSIFIED |
| Subcellular location | — |
| Keywords | — |
Druggability
Target tractability assessment (Open Targets + pocket analysis). No approved drug
| Druggability tier | MEDIUM |
| Druggability score | — |
| Pocket score | — |
| Max clinical phase | — |
Disease associations (173)
Diseases linked to this target (Open Targets).
- neurodegenerative disease · score 0.53
- sex hormone-binding globulin measurement · score 0.52
- C-reactive protein measurement · score 0.43
- body mass index · score 0.42
- alkaline phosphatase measurement · score 0.39
- testosterone measurement · score 0.39
- type 2 diabetes mellitus · score 0.38
- mean corpuscular hemoglobin concentration · score 0.38
- body fat percentage · score 0.37
- neonatal diabetes mellitus · score 0.37
3D Structure (1)
Experimental (PDB) and predicted (AlphaFold) structures for this protein.
| Structure | Source | Method | Mean pLDDT | Resolution (Å) |
| AF-Q9UBC0-F1 | alphafold | PREDICTED | 59.40 | — |
Amino-acid sequence (465 residues)
MNAQLTMEAI GELHGVSHEP VPAPADLLGG SPHARSSVAH RGSHLPPAHP RSMGMASLLD GGSGGGDYHH HHRAPEHSLA GPLHPTMTMA CETPPGMSMP TTYTTLTPLQ PLPPISTVSD KFPHHHHHHH HHHHPHHHQR LAGNVSGSFT LMRDERGLAS MNNLYTPYHK DVAGMGQSLS PLSSSGLGSI HNSQQGLPHY AHPGAAMPTD KMLTPNGFEA HHPAMLGRHG EQHLTPTSAG MVPINGLPPH HPHAHLNAQG HGQLLGTARE PNPSVTGAQV SNGSNSGQME EINTKEVAQR ITTELKRYSI PQAIFAQRVL CRSQGTLSDL LRNPKPWSKL KSGRETFRRM WKWLQEPEFQ RMSALRLAAC KRKEQEHGKD RGNTPKKPRL VFTDVQRRTL HAIFKENKRP SKELQITISQ QLGLELSTVS NFFMNARRRS LDKWQDEGSS NSGNSSSSSS TCTKA
Explore Hepatocyte nuclear factor 6 with MolForge
Find binders, run structure-based screening, and map this target across
diseases and approved drugs with our AI-powered platform.
Browse all targets